Leadership change ahead for Oxford Nanopore
Financial Times (FT) - 11-Aug-2025Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
Quantified Self News
GLP-1 drug semaglutide linked to significant age reversal in study
Futurism - 08-Aug-2025Semaglutide study reveals slowed aging in key organs and up to five years’ brain age reversal
New obesity pill shows 12% weight loss in trials
BBC - 08-Aug-2025Orforglipron offers a needle-free option for tackling obesity, pending global approval
Smartwatches miss the mark on stress detection, study finds
The Guardian - 08-Aug-2025Research shows wearables often misread stress, better at tracking sleep than emotions
Cook fresh, drop pounds: whole foods beat processed in weight loss stud
The Guardian - 04-Aug-2025Minimally processed diets cut weight, fat, and cravings better than ultra-processed ones
Sava raises $19m for next-gen glucose monitoring wearable
Longevity Technology - 31-Jul-2025With $19 million funding, the startup plans regulatory approvals and scaling
The future of weight loss might be one injection away
Live Forever Club - 18-Jul-2025This may be a way to treat lifestyle diseases at the root, biologically and sustainably
Long-term obesity makes young adults biologically older
Live Forever Club - 16-Jul-2025Staying healthy young can keep your body younger inside
Clearing senescent cells may treat obesity-linked diabetes and organ damage
Live Forever Club - 15-Jul-2025Removing these aged cells may improve organ function
Digital biomarkers can track your biological age using wearables and phones
Live Forever Club - 28-Jun-2025These easy tools could help people spot health risks early
New fat-burning pill offers alternative to weight-loss injections
Independent - 24-Jun-2025Fat-burning pill preserves appetite and muscle; safe in early trials
Biological age tests: science or hype?
The Conversation (UK) - 24-Jun-2025Costly DNA tests claim to reveal your true age, but their personal value remains uncertain
NHS to sequence DNA of all newborns in groundbreaking genomic health plan
BBC - 21-Jun-2025Plan to map all babies' DNA by 2030; aims to spot 7,000 rare diseases with early interventions
Diabetes and weight loss drugs may raise risk of eye damage in older patients
The Guardian - 05-Jun-2025Study links GLP-1 drugs to higher risk of macular degeneration in diabetics over 60
Enhanced scans for dense breasts could save 700 lives annually, UK study finds
The Guardian - 21-May-2025Extra imaging boosts cancer detection where mammograms fall short, study suggests
23andMe’s fall from fame ends in Regeneron takeover
BBC - 19-May-2025Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
Fractyl unveils gene therapy that mimics natural GLP-1 for diabetes and obesity
Fractyl - 17-May-2025Therapy cut blood sugar by >200 mg/dL & doubled insulin with 5x less GLP-1 than standard drugs
Mounjaro outperforms Wegovy in landmark weight-loss trial
BBC - 12-May-2025Trial reveals key differences in how leading obesity drugs perform and what they offer patients
Annual blood test could revolutionize cancer detection
Independent - 09-May-2025Annual screening could halve late-stage cancers and cut deaths by 21% in five years
Sweet deception: how sucralose may be fuelling your hunger
CNN - 29-Mar-2025A new study reveals that the popular sugar substitute activates brain regions that increase appetite
23andMe files for bankruptcy after data breach and financial struggles
BBC - 24-Mar-2025Company is looking for a buyer, raising concerns about the security of customer DNA data
Marriage linked to higher obesity risk in men, but not women
The Guardian - 12-Mar-2025Researchers examine how lifestyle and social habits drive weight gain in married men
Genetic link between overeating in labradors and humans discovered
BBC - 06-Mar-2025A newly identified gene variation reveals the biological drivers of obesity in dogs and humans
Global obesity crisis: over half of adults projected to be overweight by 2050
BBC - 04-Mar-2025A new study warns of rising obesity rates and the need for urgent action
AbbVie joins the obesity drug race with $2.2b Gubra deal
Endpoints News - 03-Mar-2025The pharma giant bets on amylin therapy to enter the weight-loss market
Display all news
